Dynamics of tumor–CD4+–cytokine–host cells interactions with treatments
Xiaochuan Hu and
Sophia R.-J. Jang
Applied Mathematics and Computation, 2018, vol. 321, issue C, 700-720
Abstract:
Mathematical models of interactions between tumor cells, CD4+ T cells, cytokines, and host cells are proposed to investigate the role of CD4+ on tumor regression. Our results suggest that host cells along with the mechanism of production of CD4+ T cells play important roles in driving tumor dynamics. Cancer cells can be eradicated if the tumor has a small growth rate and is also not competitive. Treatments by either CD4+, cytokines, or a combination of the two are applied to study their effectiveness. It is concluded that doses of treatments along with the tumor size are critical in determining the fate of the tumor. Tumor cells can be eliminated completely if doses of treatments by cytokine are large. The treatments are in general more effective if the tumor size is smaller. Bistability is observed in all of the models with or without the treatment strategies indicating that there is a window of opportunity for clearing off the tumor cells.
Keywords: Tumor; Immunotherapy; Cytokine; Ordinary differential equations; Global stability; Bistability (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0096300317307828
Full text for ScienceDirect subscribers only
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:eee:apmaco:v:321:y:2018:i:c:p:700-720
DOI: 10.1016/j.amc.2017.11.009
Access Statistics for this article
Applied Mathematics and Computation is currently edited by Theodore Simos
More articles in Applied Mathematics and Computation from Elsevier
Bibliographic data for series maintained by Catherine Liu ().